Table 3.
Variables | All (n = 60) | Anterograde (n = 31) | Retrograde (n = 29) | P value |
---|---|---|---|---|
mRS score at 90 days 0–2, n (%) | 30 (50.0%) | 10 (32.3%) | 20 (69.0%) | 0.004 |
Mortality at 90 days, n (%) | 12 (20.0%) | 10 (32.3%) | 2 (6.9%) | 0.01 |
Safety outcomes, n (%) | ||||
sICH | 7 (11.7%) | 5 (16.1%) | 2 (6.9%) | 0.43 |
aICH | 29 (48.3%) | 16 (51.6%) | 13 (44.8%) | 0.60 |
Procedure and device related complications, n (%) | ||||
Arterial dissection | 2 (3.3%) | 2 (6.5%) | 0 | 0.49 |
Arterial perforation | 0 | 0 | 0 | N/A |
Stent fracture | 0 | 0 | 0 | N/A |
Stent deployment failure | 0 | 0 | 0 | N/A |
mRS: modified Rankin scale; sICH: symptomatic intracerebral haemorrhage; aICH: asymptomatic intracerebral haemorrhage.